These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33475177)

  • 1. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives.
    Wang Z; Li Z; Ji H
    Med Res Rev; 2021 Jul; 41(4):2109-2129. PubMed ID: 33475177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors.
    Zhang H; Bao Y; Liu C; Li J; Zhu D; Zhang Q
    Future Med Chem; 2021 May; 13(10):927-940. PubMed ID: 33849283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Luo W; Zhang Y; Ji H
    J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
    Yan M; Li G; An J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
    Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
    DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling.
    Koelman EMR; Yeste-Vázquez A; Grossmann TN
    Bioorg Med Chem; 2022 Sep; 70():116920. PubMed ID: 35841828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
    Catrow JL; Zhang Y; Zhang M; Ji H
    J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
    Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
    Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
    Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
    Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin's Interactions with Its Nuclear Partners.
    Zhang H; Liu C; Zhu D; Zhang Q; Li J
    J Med Chem; 2023 Jan; 66(1):1-31. PubMed ID: 36583662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Li Z; Zhang M; Teuscher KB; Ji H
    J Med Chem; 2021 Aug; 64(15):11195-11218. PubMed ID: 34270257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives.
    Yang P; Zhu Y; Zheng Q; Meng S; Wu Y; Shuai W; Sun Q; Wang G
    Eur J Med Chem; 2022 Dec; 243():114789. PubMed ID: 36183504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting β-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of Antigen Presentation of cDC1 Cells.
    Zhu W; Liu C; Xi K; Li A; Shen LA; Li Y; Jia M; He Y; Chen G; Liu C; Chen Y; Chen K; Sun F; Zhang D; Duan C; Wang H; Wang D; Zhao Y; Meng X; Zhu D
    J Med Chem; 2024 Aug; 67(15):12485-12520. PubMed ID: 38912577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
    Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
    J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Quereda V; Frydman SM; Ming Q; Luca VC; Duckett DR; Ji H
    J Med Chem; 2021 Aug; 64(16):12109-12131. PubMed ID: 34382808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin.
    Grossmann TN; Yeh JT; Bowman BR; Chu Q; Moellering RE; Verdine GL
    Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17942-7. PubMed ID: 23071338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Zhang M; Wang Z; Zhang Y; Guo W; Ji H
    J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.